IMDX
Insight Molecular Diagnostics
IMDX
IMDX
33 hedge funds and large institutions have $22.4M invested in Insight Molecular Diagnostics in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
67% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 12
Holders
33
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$472K | |
| 2 | +$316K | |
| 3 | +$149K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$101K |
| 5 |
WJA
Williams Jones & Associates
New York
|
+$39K |
Top Sellers
| 1 | -$355K | |
| 2 | -$86.3K | |
| 3 | -$62K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$39K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$37K |